Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Adeno-associated virus (AAV) receptors and attachment factors are a diverse group of cell-surface molecules that facilitate the binding and internalization of AAV capsids into host cells. This process typically involves a two-step mechanism: initial low-affinity attachment to glycans followed by high-affinity binding to a proteinaceous entry receptor. Primary attachment factors include heparan sulfate proteoglycans (HSPG), sialic acid, and galactose, which vary in usage across different AAV serotypes [2, 3]. The most critical protein receptor identified is the Adeno-associated virus receptor (AAVR, also known as KIAA0319L), which is essential for the entry of most AAV serotypes by facilitating trafficking from the cell surface to the Golgi apparatus [1]. Other co-receptors, such as GPR108, FGFR1, c-Met, and various integrins, further modulate the efficiency and specificity of viral entry [4, 6]. Understanding these interactions is vital for the development of AAV-based gene therapies, as receptor distribution determines viral tropism and overall therapeutic efficacy [5]. Citations: [1] Pillay, S., et al. (2016). Nature. [2] Summerford, C., & Samulski, R. J. (1998). Journal of Virology. [3] Bell, C. L., et al. (2011). Journal of Virology. [4] Dudek, A. M., et al. (2018). Molecular Therapy. [5] Mingozzi, F., & High, K. A. (2011). Nature Reviews Genetics. [6] Qing, K., et al. (1999). Nature Medicine.
AAV capsids utilize cell-surface glycans for initial attachment followed by high-affinity binding to proteinaceous receptors to trigger receptor-mediated endocytosis and retrograde transport to the nucleus.
6 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Adeno-associated virus receptors and attachment factors (AAV receptors).